Improvements in Survival and Clinical Benefit With Gemcitabine as First-Line Therapy for Patients With Advanced Pancreas Cancer: A Randomized Trial.
Saved in:
| Title: | Improvements in Survival and Clinical Benefit With Gemcitabine as First-Line Therapy for Patients With Advanced Pancreas Cancer: A Randomized Trial. |
|---|---|
| Authors: | Burris HA 3rd; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA., Moore MJ; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA., Andersen J; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA., Green MR; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA., Rothenberg ML; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA., Modiano MR; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA., Cripps MC; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA., Portenoy RK; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA., Storniolo AM; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA., Tarassoff P; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA., Nelson R; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA., Dorr FA; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA., Stephens CD; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA., Von Hoff DD; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA. |
| Source: | Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Dec 20; Vol. 41 (36), pp. 5482-5492. |
| Publication Type: | Clinical Trial; Research Support, Non-U.S. Gov't; Journal Article |
| Journal Info: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38100992 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Improvements in Survival and Clinical Benefit With Gemcitabine as First-Line Therapy for Patients With Advanced Pancreas Cancer: A Randomized Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Burris+HA+3rd%22">Burris HA 3rd</searchLink>; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA.<br /><searchLink fieldCode="AU" term="%22Moore+MJ%22">Moore MJ</searchLink>; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA.<br /><searchLink fieldCode="AU" term="%22Andersen+J%22">Andersen J</searchLink>; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA.<br /><searchLink fieldCode="AU" term="%22Green+MR%22">Green MR</searchLink>; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA.<br /><searchLink fieldCode="AU" term="%22Rothenberg+ML%22">Rothenberg ML</searchLink>; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA.<br /><searchLink fieldCode="AU" term="%22Modiano+MR%22">Modiano MR</searchLink>; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA.<br /><searchLink fieldCode="AU" term="%22Cripps+MC%22">Cripps MC</searchLink>; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA.<br /><searchLink fieldCode="AU" term="%22Portenoy+RK%22">Portenoy RK</searchLink>; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA.<br /><searchLink fieldCode="AU" term="%22Storniolo+AM%22">Storniolo AM</searchLink>; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA.<br /><searchLink fieldCode="AU" term="%22Tarassoff+P%22">Tarassoff P</searchLink>; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA.<br /><searchLink fieldCode="AU" term="%22Nelson+R%22">Nelson R</searchLink>; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA.<br /><searchLink fieldCode="AU" term="%22Dorr+FA%22">Dorr FA</searchLink>; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA.<br /><searchLink fieldCode="AU" term="%22Stephens+CD%22">Stephens CD</searchLink>; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA.<br /><searchLink fieldCode="AU" term="%22Von+Hoff+DD%22">Von Hoff DD</searchLink>; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228309333%22">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</searchLink> [J Clin Oncol] 2023 Dec 20; Vol. 41 (36), pp. 5482-5492. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial; Research Support, Non-U.S. Gov't; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Clinical+Oncology%22">American Society of Clinical Oncology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309333 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1527-7755 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220732183X%22">0732183X </searchLink><i>NLM ISO Abbreviation: </i>J Clin Oncol <i>Subsets: </i>MEDLINE; PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38100992 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1200/JCO.22.02777 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 5482 Titles: – TitleFull: Improvements in Survival and Clinical Benefit With Gemcitabine as First-Line Therapy for Patients With Advanced Pancreas Cancer: A Randomized Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Burris HA 3rd – PersonEntity: Name: NameFull: Moore MJ – PersonEntity: Name: NameFull: Andersen J – PersonEntity: Name: NameFull: Green MR – PersonEntity: Name: NameFull: Rothenberg ML – PersonEntity: Name: NameFull: Modiano MR – PersonEntity: Name: NameFull: Cripps MC – PersonEntity: Name: NameFull: Portenoy RK – PersonEntity: Name: NameFull: Storniolo AM – PersonEntity: Name: NameFull: Tarassoff P – PersonEntity: Name: NameFull: Nelson R – PersonEntity: Name: NameFull: Dorr FA – PersonEntity: Name: NameFull: Stephens CD – PersonEntity: Name: NameFull: Von Hoff DD IsPartOfRelationships: – BibEntity: Dates: – D: 20 M: 12 Text: 2023 Dec 20 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1527-7755 Numbering: – Type: volume Value: 41 – Type: issue Value: 36 Titles: – TitleFull: Journal of clinical oncology : official journal of the American Society of Clinical Oncology Type: main |
| ResultId | 1 |